Cargando…

The use of eculizumab as a bridge to retransplantation for chronic antibody-mediated rejection in a heart transplant recipient: a case report

BACKGROUND: Antibody-mediated rejection (AMR) remains a major management challenge in heart transplantation given the complexity of pathological diagnosis and dearth of evidence for effective management. Eculizumab, an anti-C5 monoclonal antibody which inhibits terminal complement activation, has be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kearney, Katherine, Macdonald, Peter, Hayward, Christopher, Muthiah, Kavitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110694/ https://www.ncbi.nlm.nih.gov/pubmed/33997604 http://dx.doi.org/10.1093/ehjcr/ytab180

Ejemplares similares

Heart retransplantation following COVID-19 illness in a heart transplant recipient
por: Soquet, Jerome, et al.
Publicado: (2020)

Liver retransplantation for adult recipients
por: Hwang, Shin, et al.
Publicado: (2013)

Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience
por: Zhu, Lan, et al.
Publicado: (2016)

Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
por: Cehic, Matthew G., et al.
Publicado: (2019)

Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial
por: Marks, William H., et al.
Publicado: (2019)

Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation
por: Yerly, Patrick, et al.
Publicado: (2022)

Heart Retransplantation: Candidacy, Outcomes, and Management
por: Barghash, Maya H., et al.
Publicado: (2019)

Use of TandemHeart as Bridge to Recovery for Antibody-Mediated Rejection in a Heart Transplant Patient
por: Rodriguez-Escudero, Juan P., et al.
Publicado: (2020)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

Retransplantation Outcomes at a Large Lung Transplantation Program
por: Ren, Dewei, et al.
Publicado: (2018)

Coincidence of cellular and antibody mediated rejection in heart transplant recipients – preliminary report
por: Zakliczyński, Michał, et al.
Publicado: (2014)

ANTIBODY-MEDIATED REJECTION IN HEART TRANSPLANT RECIPIENT AFTER COVID-19 INFECTION
por: Daso, Gabrielle, et al.
Publicado: (2023)

A Kidney Transplant Recipient on Prophylactic Eculizumab Presenting With Myalgia
por: Shivakumar, Oshini, et al.
Publicado: (2022)

CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model
por: ZHUANG, JIAWEI, et al.
Publicado: (2014)

Long-term Use of Eculizumab in Kidney Transplant Recipients
por: Milan Manani, Sabrina, et al.
Publicado: (2018)

Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature
por: Tran, Duy, et al.
Publicado: (2016)

The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation
por: Brüggenwirth, Isabel M. A., et al.
Publicado: (2021)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome
por: Durán, Carlos E., et al.
Publicado: (2012)

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
por: Cheung, Chee Kay, et al.
Publicado: (2019)

Graft-recipient-weight ratio and lowered immunosuppression is important for the success of adult liver retransplantation
por: Rhu, Jinsoo, et al.
Publicado: (2023)

Lung retransplantation in the modern era
por: Rucker, A. Justin, et al.
Publicado: (2021)

Single Lung Retransplantation for Graft Infarction due to Herniation of Heart
por: Mohite, Prashant N., et al.
Publicado: (2013)

Antibody-Mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient
por: Arjuna, Ashwini, et al.
Publicado: (2021)

Lung retransplantation for chronic lung allograft dysfunction
por: Kosiorowska, Monika, et al.
Publicado: (2019)

Retransplantation in Late Hepatic Artery Thrombosis: Graft Access and Transplant Outcome
por: Buchholz, Bettina M., et al.
Publicado: (2017)

Retransplantation for COVID-19-related lung graft failure: A case report of successful outcome in a critically ill lung transplant recipient
por: Ntiamoah, Prince, et al.
Publicado: (2023)

THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design
por: Raven, Lisa M, et al.
Publicado: (2023)

Value of Renal Histology in Predicting Cardiorenal Outcomes in Heart Transplant–listed Patients
por: Barua, Sumita, et al.
Publicado: (2022)

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
por: Nourié, Nicole, et al.
Publicado: (2022)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
por: Weum Abrahamsen, Ingerid, et al.
Publicado: (2020)

Liver retransplantation: Timing is equally important
por: Li, Le, et al.
Publicado: (2023)

Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
por: Pham, Christine, et al.
Publicado: (2021)

Evaluation of Thymic Output and Regulatory T Cells in Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection
por: Shahi, Abbas, et al.
Publicado: (2021)

Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection
por: Afzali, Shima, et al.
Publicado: (2021)

Multispecies Outbreak of Nocardia Infections in Heart Transplant Recipients and Association with Climate Conditions, Australia
por: Li, Jonathan, et al.
Publicado: (2022)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
por: Crespo, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ocl7q71705hmep09omk03atiqi